Glenmark Pharmaceuticals Limited (NSE: GLENMARK)
1,702.70
-6.75 (-0.39%)
Sep 6, 2024, 3:29 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 480.48 billion as of September 6, 2024. Its market cap has increased by 122.24% in one year.
Market Cap
480.48B
Enterprise Value
476.19B
Revenue
128.61B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,702.70
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 480.48B, an increase of 41,706.35%. That is a compound annual growth rate of 29.62%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Reliance Industries Limited | 19.82T |
Tata Consultancy Services Limited | 16.12T |
HDFC Bank Limited | 12.48T |
Bharti Airtel Limited | 9,202.60B |
ICICI Bank Limited | 8,511.22B |
Infosys Limited | 7,877.25B |
State Bank of India | 6,983.51B |
Hindustan Unilever Limited | 6,669.20B |